Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – results from the prospective German TMK cohort study.

Fietz, T., Tesch, H., Rauh, J., Boller, E., Kruggel, L., Jänicke, M., Marschner, N., 2017.

The Breast 34, 122–130. doi:http://dx.doi.org/10.1016/j.breast.2017.05.014

Studie: TMK; Indikation: Mammakarzinom; Jahr: 2017; Veranstaltung: -; Journal: The Breast

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com